UT MD ANDERSON CANCER CENTER Revenue and Competitors
Employee Data
- UT MD ANDERSON CANCER CENTER has 663 Employees.
- UT MD ANDERSON CANCER CENTER grew their employee count by 12% last year.
UT MD ANDERSON CANCER CENTER's People
Name | Title | Email/Phone |
---|---|---|
1 | Program Coordinator, Office SVP/Chief Philanthropy Officer, Philanthropy Office. | Reveal Email/Phone |
2 | Chief Fellow Pediatric Hematology/Oncology | Reveal Email/Phone |
3 | Associate VP, Research Finance | Reveal Email/Phone |
4 | Director, SVP Office, People, Culture and Infrastructure | Reveal Email/Phone |
5 | Associate Director | Reveal Email/Phone |
6 | Director, Sleep Center | Reveal Email/Phone |
7 | Professor, General Oncology Clinical Medical Director, International Center | Reveal Email/Phone |
8 | Associate Director, Research Planning & Development | Reveal Email/Phone |
9 | Associate Director Research Planning & Development | Reveal Email/Phone |
10 | Associate Director, Enterprise Data Platforms | Reveal Email/Phone |
UT MD ANDERSON CANCER CENTER Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 84 | -1% | N/A | N/A |
#2 | N/A | 59 | 28% | N/A | N/A |
#3 | N/A | 45 | -18% | N/A | N/A |
#4 | N/A | 79 | 58% | N/A | N/A |
#5 | N/A | 182 | 14% | N/A | N/A |
#6 | N/A | 57 | 30% | N/A | N/A |
#7 | N/A | 283 | 9% | N/A | N/A |
#8 | N/A | 109 | 40% | N/A | N/A |
#9 | N/A | 77 | 33% | N/A | N/A |
#10 | $1.7M | 35 | -57% | N/A | N/A |
What Is UT MD ANDERSON CANCER CENTER?
UT MD ANDERSON CANCER CENTER is a hospital & health care company based out of 1515 HOLCOMBE BLVD, Houston, Texas, United States.
keywords:N/AN/A
Total Funding
663
Number of Employees
N/A
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3840M | 663 | -2% | N/A |
#2 | $133.5M | 664 | -13% | N/A |
#3 | $211.5M | 665 | 10% | N/A |
#4 | $306.3M | 667 | 8% | N/A |
#5 | $204.6M | 668 | 3% | N/A |